BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12675512)

  • 1. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA; Rho HM
    Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.
    Choi M; Lee H; Rho HM
    IUBMB Life; 2002 Jun; 53(6):309-17. PubMed ID: 12625370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression of the human p53 gene by hepatitis B viral X protein.
    Lee SG; Rho HM
    Oncogene; 2000 Jan; 19(3):468-71. PubMed ID: 10656696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ; Ki SH; Brooks C; Kim SG
    Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct repression of the Mcl-1 promoter by E2F1.
    Croxton R; Ma Y; Song L; Haura EB; Cress WD
    Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression.
    Du J; Liang X; Liu Y; Qu Z; Gao L; Han L; Liu S; Cui M; Shi Y; Zhang Z; Yu L; Cao L; Ma C; Zhang L; Chen Y; Sun W
    Cell Death Differ; 2009 Feb; 16(2):219-29. PubMed ID: 18927587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cysteine residues of the hepatitis B virus onco-protein HBx are not required for its interaction with RNA or with human p53.
    de Moura PR; Rui E; de Almeida Gonçalves K; Kobarg J
    Virus Res; 2005 Mar; 108(1-2):121-31. PubMed ID: 15681062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death.
    Meyer K; Basu A; Saito K; Ray RB; Ray R
    Virology; 2005 Jun; 336(2):198-207. PubMed ID: 15892961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor of activated T cells (NFAT1-C) represses the enhancer II and pregenomic promoter (EnII/Cp) of hepatitis B virus (HBV) through its responsive site GGAGA and nullifies the HBx-driven transcriptional activation.
    Lee JH; Rho HM
    IUBMB Life; 2001 Apr; 51(4):255-61. PubMed ID: 11569920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes.
    Lara-Pezzi E; Majano PL; Gómez-Gonzalo M; García-Monzón C; Moreno-Otero R; Levrero M; López-Cabrera M
    Hepatology; 1998 Oct; 28(4):1013-21. PubMed ID: 9755238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
    Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
    Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.
    Wang XW; Gibson MK; Vermeulen W; Yeh H; Forrester K; Stürzbecher HW; Hoeijmakers JH; Harris CC
    Cancer Res; 1995 Dec; 55(24):6012-6. PubMed ID: 8521383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.